Investments in Health: Development of New Drugs, Medical Equipment and Products

INDUSTRY-SPECIFIC CHARACTERISTICS
    • Женщины за здоровое общество
      Women for a Healthy Society
Date:
20 October
Time:
11:30 – 12:45

Description

Creating a new drug or medical device is always a long journey: years of research, substantial investments, trials, certification, and only then serial production. How can this path be followed so that a promising development turns into a sought-after product rather than remaining at the idea stage? Participants of the session will discuss the financing of pharmaceutical and medical-technical projects, the localization of substances, materials, and components, the organization of trials and the introduction of domestic products into clinical practice, Moscow’s opportunities: advanced industrial sites and special economic zones, cooperation of enterprises with scientific and medical organizations, instruments of support for investors, and the formation of long-term demand. We will consider the entire path of the product — from research and prototype to production, supplies, and support of application. The focus of the discussion is the distribution of risks among project participants, confirmation of the efficacy and safety of the products, as well as the conditions under which investments truly ensure the accessibility of modern solutions for patients and medical organizations. It is precisely at the intersection of science, production, and practical healthcare that a product is born which changes the quality of life.

  • Moderator:
    • Anastasia Stolkova

      First Deputy Director for Development of the Roscongress Foundation, member of the Public Chamber of the Russian Federation Commission on Healthcare

  • Speakers:
    • Anna Meshcheryakova

      General Director of Platform Third Opinion LLC

    • Evgenia Simonova

      Project Director at Rapid-Bio LLC

    • Elena Aksenova

      Director of the Research Institute of Healthcare Organization and Medical Management of the Moscow Department of Health

    • Kamila Zarubina

      Managing Director for Investments in Biomedicine at SK Capital, Head of the Department of Technological Leadership at Sechenov University, Professor, Candidate of Biological Sciences

    • Li Yinxin

      Deputy General Manager of ZHEJIANG JUNCONTROL INTELLIGENT TECHNOLOGY CO., LTD

To improve your experience on the Moscow Investment and Industrial Forum website, we use cookies. By continuing to use our website, you accept the terms of the Terms of Use of Website Visitor Data and Consent to the Processing of Personal Data Using the Yandex.Metrica Service. If you do not want user data to be processed, disable cookies in your browser settings.